2021
DOI: 10.1093/ofid/ofab466.602
|View full text |Cite
|
Sign up to set email alerts
|

401. Natural History of Shedding and Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Using Intensive High-Resolution Sampling

Abstract: Background In order to mitigate the spread of SARS-CoV-2 and the COVID-19 pandemic, public health officials have recommended self-isolation, self-quarantine of exposed household contacts (HHC), and mask use to limit viral spread within households and communities. While household transmission of SARS-CoV-2 is common, risk factors for HHC transmission are poorly understood. Methods In this prospective cohort study, we enrolled … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The first was a prospective household transmission study, in which index cases with at least 1 reverse-transcription quantitative polymerase chain reaction (RT-qPCR)-confirmed SARS-CoV-2 test were enrolled along with household members. Participants were tested daily for SARS-CoV-2 ribonucleic acid (RNA) via RT-qPCR, using self-collected lower nasal swabs, and households were followed until all members tested negative for 7 consecutive days [ 18 ]. The second was a randomized, single-blind, placebo-controlled trial of Peginterferon Lambda-1a (Lambda) for reducing the duration of viral shedding or symptoms [ 19 ] in which oropharyngeal swabs were collected for 28 days after enrollment.…”
Section: Methodsmentioning
confidence: 99%
“…The first was a prospective household transmission study, in which index cases with at least 1 reverse-transcription quantitative polymerase chain reaction (RT-qPCR)-confirmed SARS-CoV-2 test were enrolled along with household members. Participants were tested daily for SARS-CoV-2 ribonucleic acid (RNA) via RT-qPCR, using self-collected lower nasal swabs, and households were followed until all members tested negative for 7 consecutive days [ 18 ]. The second was a randomized, single-blind, placebo-controlled trial of Peginterferon Lambda-1a (Lambda) for reducing the duration of viral shedding or symptoms [ 19 ] in which oropharyngeal swabs were collected for 28 days after enrollment.…”
Section: Methodsmentioning
confidence: 99%
“…We assembled a collection of samples from four prospective SARS-CoV-2 research studies: (a) a prospective household transmission study, in which index cases with at least one reverse transcription quantitative polymerase chain reaction-confirmed (RT-qPCR) SARS-CoV-2 test were enrolled along with household members. Participants were tested daily for SARS-CoV-2 RNA via RT-qPCR, using self-collected lower nasal swabs, and households were followed until all members tested negative for seven consecutive days[16]. (b) A randomized, single-blind, placebo-controlled trial of Peginterferon Lambda-1a (Lambda) for reducing the duration of viral shedding or symptoms[17] in which oropharyngeal swabs were collected for 28 days following enrollment.…”
Section: Methodsmentioning
confidence: 99%